A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells. [electronic resource]
- Biochemical and biophysical research communications 03 2017
- 298-303 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't